Skip to content

Study of prognosis of patients with rice tablet toxicity

A comparative study of prognosis of patients with rice tablet poisoning (phosphide) the new and old protocol

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014072318571N1
Enrollment
132
Registered
2014-08-04
Start date
2013-12-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

poisining. Organophosphate and carbamate insecticides

Interventions

Gasteric lavage with potassium permanganate solution1/10000 and then gavaged with 100g sharchol and mixture of 100cc coconut oil and 50cc sodium bicarbonate and sorbitol. Patients transport to ICU and
Treatment - Drugs

Sponsors

Research Deputy of Kermanshah University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Consumed aluminum phosphide compounds and the symptoms of poisoning including: retro sternal pain; hypotention and metabolic acidosis. Exclusion criteria:Dead patients; history of other drugs toxicity; admission after 24h of concumption.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Renal complications. Timepoint: Day. Method of measurement: watch.;Liver complications. Timepoint: Day. Method of measurement: watch.;Cardiovascular complications. Timepoint: day. Method of measurement: watch.;Survival rate. Timepoint: From coming to hospital to cure or expire. Method of measurement: watch.;Duration of admission in ICU and ward. Timepoint: Hour. Method of measurement: watch.

Secondary

MeasureTime frame
Organ damage. Timepoint: day. Method of measurement: day.;Organ damage. Timepoint: day to day. Method of measurement: daily.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Hedayat Yaghoobi

Kermanshah University of Medical Science

R.Hyaghoobi@kums.ac.ir+98 83 3427 6301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026